Age-dependent pattern of cerebellar susceptibility to bilirubin neurotoxicity in vivo in mice

DMM Disease Models and Mechanisms

Volumn 7, Issue 9, 2014, Pages 1057-1068

  Bortolussi, Giulia ^a   Baj, Gabriele ^b   Vodret, Simone ^a   Viviani, Giulia ^a   Bittolo, Tamara ^b   Muro, Andrés F ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

BIND; Mouse model; Neonatal jaundice; Phototherapy; Ugt1

Indexed keywords

BILIRUBIN; GLUCURONOSYLTRANSFERASE 1A1;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; BILIRUBIN INDUCED NEUROLOGICAL DAMAGE; BRAIN DEVELOPMENT; BRAIN HISTOLOGY; CONTROLLED STUDY; DENDRITIC ARBORIZATION; DENDRITIC SPINE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; IN VIVO STUDY; MALE; MOUSE; NEONATAL HYPERBILIRUBINEMIA; NERVE CELL LESION; NERVE DEGENERATION; NERVE FIBER; NEUROTOXICITY; NEWBORN; NEWBORN JAUNDICE; NEWBORN PERIOD; NONHUMAN; PERINATAL PERIOD; PHENOTYPE; PHOTOTHERAPY; POSTNATAL DEVELOPMENT; PURKINJE CELL; SURVIVAL TIME; AGING; ANIMAL; C57BL MOUSE; CEREBELLUM; HUMAN; JAUNDICE, NEONATAL; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; ANIMALS; BILIRUBIN; CEREBELLUM; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; MICE; MICE, INBRED C57BL; PHENOTYPE; PHOTOTHERAPY;

EID: 84907198716     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.016535     Document Type: Article

References (64)

1. Astrof, S., Kirby, A., Lindblad-Toh, K., Daly, M. and Hynes, R. O. (2007). Heart development in fibronectin-null mice is governed by a genetic modifier on chromosome four. Mech. Dev. 124, 551-558.
2. Baj, G., Patrizio, A., Montalbano, A., Sciancalepore, M. and Tongiorgi, E. (2014). Developmental and maintenance defects in Rett syndrome neurons identified by a new mouse staging system in vitro. Front Cell Neurosci 8, 18.
3. Bhutani, V. K. and Johnson, L. (2006). Kernicterus in late preterm infants cared for as term healthy infants. Semin. Perinatol. 30, 89-97.
4. Bhutani, V. K. and Johnson, L. (2009a). Kernicterus in the 21st century: frequently asked questions. J. Perinatol. 29 Suppl. 1, S20-S24.
5. Bhutani, V. K. and Johnson, L. (2009b). A proposal to prevent severe neonatal hyperbilirubinemia and kernicterus. J. Perinatol. 29 Suppl. 1, S61-S67.
6. Biran, V., Verney, C. and Ferriero, D. M. (2012). Perinatal cerebellar injury in human and animal models. Neurol. Res. Int. 2012, 858929.
7. Bortolussi, G., Zentilin, L., Baj, G., Giraudi, P., Bellarosa, C., Giacca, M., Tiribelli, C. and Muro, A. F. (2012). Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer. FASEB J. 26, 1052-1063.
8. Bosma, P. J., Seppen, J., Goldhoorn, B., Bakker, C., Oude Elferink, R. P., Chowdhury, J. R., Chowdhury, N. R. and Jansen, P. L. (1994). Bilirubin UDPglucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J. Biol. Chem. 269, 17960-17964.
9. Bulmer, A. C., Verkade, H. J. and Wagner, K. H. (2013). Bilirubin and beyond: a review of lipid status in Gilberts syndrome and its relevance to cardiovascular disease protection. Prog. Lipid Res. 52, 193-205.
10. Chen, Y. J. and Kang, W. M. (1995). Effects of bilirubin on visual evoked potentials in term infants. Eur. J. Pediatr. 154, 662-666.
11. Chowdhury, J. R., Kondapalli, R. and Chowdhury, N. R. (1993). Gunn rat: a model for inherited deficiency of bilirubin glucuronidation. Adv. Vet. Sci. Comp. Med. 37, 149-173.
12. Conlee, J. W. and Shapiro, S. M. (1997). Development of cerebellar hypoplasia in jaundiced Gunn rats: a quantitative light microscopic analysis. Acta Neuropathol. 93, 450-460.
13. Doetschman, T. (2009). Influence of genetic background on genetically engineered mouse phenotypes. Methods Mol. Biol. 530, 423-433.
14. Doré, S. and Snyder, S. H. (1999). Neuroprotective action of bilirubin against oxidative stress in primary hippocampal cultures. Ann. N. Y. Acad. Sci. 890, 167-172.
15. Doré, S., Takahashi, M., Ferris, C. D., Zakhary, R., Hester, L. D., Guastella, D. and Snyder, S. H. (1999). Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl. Acad. Sci. USA 96, 2445-2450.
16. Erlinger, S., Arias, I. M. and Dhumeaux, D. (2014). Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. Gastroenterology 146, 1625-1638.
17. Escobar, G. J., Greene, J. D., Hulac, P., Kincannon, E., Bischoff, K., Gardner, M. N., Armstrong, M. A. and France, E. K. (2005). Rehospitalisation after birth hospitalisation: patterns among infants of all gestations. Arch. Dis. Child. 90, 125-131.
18. Fagiuoli, S., Daina, E., DAntiga, L., Colledan, M. and Remuzzi, G. (2013). Monogenic diseases that can be cured by liver transplantation. J. Hepatol. 59, 595-612.
19. Fonnum, F. and Lock, E. A. (2000). Cerebellum as a target for toxic substances. Toxicol. Lett. 112-113, 9-16.
20. George, E. L., Baldwin, H. S. and Hynes, R. O. (1997). Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood 90, 3073-3081.
21. Haldipur, P., Bharti, U., Alberti, C., Sarkar, C., Gulati, G., Iyengar, S., Gressens, P. and Mani, S. (2011). Preterm delivery disrupts the developmental program of the cerebellum. PLoS ONE 6, e23449.
22. Hankø, E., Lindemann, R. and Hansen, T. W. (2001). Spectrum of outcome in infants with extreme neonatal jaundice. Acta Paediatr. 90, 782-785.
23. Hansen, T. W. (2011). The role of phototherapy in the crash-cart approach to extreme neonatal jaundice. Semin. Perinatol. 35, 171-174.
24. Hansen, T. W., Nietsch, L., Norman, E., Bjerre, J. V., Hascoet, J. M., Mreihil, K. and Ebbesen, F. (2009). Reversibility of acute intermediate phase bilirubin encephalopathy. Acta Paediatr. 98, 1689-1694.
25. Horsfall, L. J., Nazareth, I. and Petersen, I. (2012). Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort. Circulation 126, 2556-2564.
26. Iyanagi, T., Watanabe, T. and Uchiyama, Y. (1989). The 3-methylcholanthreneinducible UDP-glucuronosyltransferase deficiency in the hyperbilirubinemic rat (Gunn rat) is caused by a-1 frameshift mutation. J. Biol. Chem. 264, 21302-21307.
27. Johnson, L., Sarmiento, F., Blanc, W. A. and Day, R. (1959). Kernicterus in rats with an inherited deficiency of glucuronyl transferase. AMA J. Dis. Child. 97, 591-608.
28. Kaplan, M. and Hammerman, C. (2005). Bilirubin and the genome: the hereditary basis of unconjugated neonatal hyperbilirubinemia. Curr. Pharmacogenomics 3, 21-42.
29. Kaplan, M., Bromiker, R. and Hammerman, C. (2011). Severe neonatal hyperbilirubinemia and kernicterus: are these still problems in the third millennium? Neonatology 100, 354-362.
30. Karen, T., Bucher, H. U. and Fauchre, J. C. (2009). Comparison of a new transcutaneous bilirubinometer (Bilimed) with serum bilirubin measurements in preterm and full-term infants. BMC Pediatr. 9, 70.
31. Keenan, W. J., Novak, K. K., Sutherland, J. M., Bryla, D. A. and Fetterly, K. L. (1985). Morbidity and mortality associated with exchange transfusion. Pediatrics 75, 417-421.
32. Keino, H. and Kashiwamata, S. (1989). Critical period of bilirubin-induced cerebellar hypoplasia in a new Sprague-Dawley strain of jaundiced Gunn rats. Neurosci. Res. 6, 209-215.
33. Keino, H., Sato, H., Semba, R., Aono, S., Aoki, E. and Kashiwamata, S. (1985-1986). Mode of prevention by phototherapy of cerebellar hypoplasia in a new Sprague-Dawley strain of jaundiced Gunn rats. Pediatr. Neurosci. 12, 145-150.
34. Lauer, B. J. and Spector, N. D. (2011). Hyperbilirubinemia in the newborn. Pediatr. Rev. 32, 341-349.
35. LeCouter, J. E., Kablar, B., Hardy, W. R., Ying, C., Megeney, L. A., May, L. L. and Rudnicki, M. A. (1998a). Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene. Mol. Cell. Biol. 18, 7455-7465.
36. LeCouter, J. E., Kablar, B., Whyte, P. F., Ying, C. and Rudnicki, M. A. (1998b). Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development 125, 4669-4679.
37. Limperopoulos, C., Soul, J. S., Gauvreau, K., Huppi, P. S., Warfield, S. K., Bassan, H., Robertson, R. L., Volpe, J. J. and du Plessis, A. J. (2005). Late gestation cerebellar growth is rapid and impeded by premature birth. Pediatrics 115, 688-695.
38. Maisels, M. J. and McDonagh, A. F. (2008). Phototherapy for neonatal jaundice. N. Engl. J. Med. 358, 920-928.
39. Muro, A. F., Marro, M. L., Gajovi?, S., Porro, F., Luzzatto, L. and Baralle, F. E. (2000). Mild spherocytic hereditary elliptocytosis and altered levels of alpha-and gamma-adducins in beta-adducin-deficient mice. Blood 95, 3978-3985.
40. Novotný, L. and Vítek, L. (2003). Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp. Biol. Med. (Maywood) 228, 568-571.
41. Oh, W., Tyson, J. E., Fanaroff, A. A., Vohr, B. R., Perritt, R., Stoll, B. J., Ehrenkranz, R. A., Carlo, W. A., Shankaran, S., Poole, K. et al.; National Institute of Child Health and Human Development Neonatal Research Network (2003). Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics 112, 773-779.
42. Ostrow, J. D., Pascolo, L., Shapiro, S. M. and Tiribelli, C. (2003). New concepts in bilirubin encephalopathy. Eur. J. Clin. Invest. 33, 988-997.
43. Ostrow, J. D., Pascolo, L., Brites, D. and Tiribelli, C. (2004). Molecular basis of bilirubin-induced neurotoxicity. Trends Mol. Med. 10, 65-70.
44. Pearson, H. A. (1967). Life-span of the fetal red blood cell. J. Pediatr. 70, 166-171.
45. Ranjan, A. and Mallick, B. N. (2010). A modified method for consistent and reliable Golgi-cox staining in significantly reduced time. Front Neurol 1, 157.
46. Roussel, M. F. and Hatten, M. E. (2011). Cerebellum development and medulloblastoma. Curr. Top. Dev. Biol. 94, 235-282.
47. Sawasaki, Y., Yamada, N. and Nakajima, H. (1976). Developmental features of cerebellar hypoplasia and brain bilirubin levels in a mutant (Gunn) rat with hereditary hyperbilirubinaemia. J. Neurochem. 27, 577-583.
48. Schutta, H. S. and Johnson, L. (1967). Bilirubin encephalopathy in the Gunn rat: a fine structure study of the cerebellar cortex. J. Neuropathol. Exp. Neurol. 26, 377-396.
49. Schutta, H. S. and Johnson, L. (1969). Clinical signs and morphologic abnormalities in Gunn rats treated with sulfadimethoxine. J. Pediatr. 75, 1070-1079.
50. Schutta, H. S. and Johnson, L. (1971). Electron microscopic observations on acute bilirubin encephalopathy in Gunn rats induced by sulfadimethoxine. Lab. Invest. 24, 82-89.
51. Schwertner, H. A. and Vítek, L. (2008). Gilbert syndrome, UGT1A1 28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 198, 1-11.
52. Shapiro, S. M. (2003). Bilirubin toxicity in the developing nervous system. Pediatr. Neurol. 29, 410-421.
53. Shapiro, S. M., Bhutani, V. K. and Johnson, L. (2006). Hyperbilirubinemia and kernicterus. Clin. Perinatol. 33, 387-410.
54. Sholl, D. A. (1953). Dendritic organization in the neurons of the visual and motor cortices of the cat. J. Anat. 87, 387-406.
55. Threadgill, D. W., Dlugosz, A. A., Hansen, L. A., Tennenbaum, T., Lichti, U., Yee, D., LaMantia, C., Mourton, T., Herrup, K., Harris, R. C. et al. (1995). Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269, 230-234.
56. Vítek, L., Jirsa, M., Brodanov, M., Kalab, M., Marecek, Z., Danzig, V., Novotný, L. and Kotal, P. (2002). Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 160, 449-456.
57. Volpe, J. J. (2009). Cerebellum of the premature infant: rapidly developing, vulnerable, clinically important. J. Child Neurol. 24, 1085-1104.
58. Watchko, J. F. (2006a). Hyperbilirubinemia and bilirubin toxicity in the late preterm infant. Clin. Perinatol. 33, 839-852, abstract ix.
59. Watchko, J. F. (2006b). Kernicterus and the molecular mechanisms of bilirubininduced CNS injury in newborns. Neuromolecular Med. 8, 513-530.
60. Watchko, J. F. and Jeffrey Maisels, M. (2010). Enduring controversies in the management of hyperbilirubinemia in preterm neonates. Semin. Fetal Neonatal Med. 15, 136-140.
61. Watchko, J. F. and Tiribelli, C. (2013). Bilirubin-induced neurologic damage-mechanisms and management approaches. N. Engl. J. Med. 369, 2021-2030.
62. Wennberg, R. P., Ahlfors, C. E., Bhutani, V. K., Johnson, L. H. and Shapiro, S. M. (2006). Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 117, 474-485.
63. Whitney, E. R., Kemper, T. L., Rosene, D. L., Bauman, M. L. and Blatt, G. J. (2008). Calbindin-D28k is a more reliable marker of human Purkinje cells than standard Nissl stains: a stereological experiment. J. Neurosci. Methods 168, 42-47.
64. Zuccoli, G., Pipitone, N., Haldipur, A., Brown, R. D., Jr, Hunder, G. and Salvarani, C. (2011). Imaging findings in primary central nervous system vasculitis. Clin. Exp. Rheumatol. 29 Suppl. 64, S104-S109.